Summary.-Saline extracts of human bronchogenic tumours, soluble in 50% saturated ammonium sulphate and also fractions from Sephadex G-200 chromatography were used to raise antisera in rabbits. After absorbing the antisera with normal tissue extracts, direct Ouchterlony tests were performed against tumour (adenocarcinomata and squamous cell carcinomata) and normal extracts. A precipitin reaction was given with all 11 tumour extracts tested at a concentration of 5 mg/ml whereas all the 9 normal lung control extracts did not react at concentrations up to 100 mg/ml. The possibility that this reaction could be related to histocompatibility differences between individuals is ruled out by the fact that in two cases tumour and normal tissue were obtained from the same patient. These studies and also precipitin-inhibition experiments have confirmed the existence of an antigen associated with bronchial carcinomata and have shown that, although the antigen or a cross -reacting antigen is present in normal lung tissue, the amounts are small in comparison with the amounts extracted from tumour. Antigenic activity was contained in a single absorbance peak when fractionated by Sephadex G-200 chromatography and its elution volume indicated a molecular weight of approximately 4.0 x 104 D. Further purification was achieved using isotachophoresis.
precipitin reaction was given with all 11 tumour extracts tested at a concentration of 5 mg/ml whereas all the 9 normal lung control extracts did not react at concentrations up to 100 mg/ml. The possibility that this reaction could be related to histocompatibility differences between individuals is ruled out by the fact that in two cases tumour and normal tissue were obtained from the same patient. These studies and also precipitin-inhibition experiments have confirmed the existence of an antigen associated with bronchial carcinomata and have shown that, although the antigen or a cross -reacting antigen is present in normal lung tissue, the amounts are small in comparison with the amounts extracted from tumour. Antigenic activity was contained in a single absorbance peak when fractionated by Sephadex G-200 chromatography and its elution volume indicated a molecular weight of approximately 4.0 x 104 D. Further purification was achieved using isotachophoresis.
Preliminary characterization of the antigen has shown it to be stable at pH 4*5, resistant to heating at 50°C for 30 min, to migrate on immunoelectrophoresis with a cationic mobility at pH 8*5 and to be immunologically distinct from carcinoembryonic antigen.
IMMUJNOCHEMICAL studies have shown the existence of several human tumour associated antigens (AJexander, 1972; Cinader, 1972; Avis and Lewis, 1973) . Two of the most widely studied are carcinoembryonic antigen (CEA), originally thought to be specifically associated with colon carcinoma (Gold and Freedman, 1965 ) and alpha-foetoprotein (Tatarinov, 1964) found in the serum of patients with hepatocellular carcinoma or teratoma. Both of these sntigens have been found in foetal tissues. Other studies (Yachi et al., 1968) employing absorbed heterologous antisera have demonstrated by double diffusion at least 2 tumour associated antigens in saline extracts of bronchial carcinomata. These antigens 27 were both soluble in 50% saturated ammonium sulphate but appeared to differ in molecular size. The smaller antigen (7S) in particular was not only related to lung cancer-an identical or partially related antigen was found also in tumours of colon, stomach, pancreas, kidney and liver. It had an electrophoretic mobility in the alpha-beta region (pH 8.6) and is very similar in character to a lung tumour antigen recently reported by Sega et al. (1974) w%Aere generally tested at 5 mg/ml and the inormal tissue extracts at a range of concentrations up to 100 mg/ml. Immunoelectrophoresis was carried out in 1-5% Agar gel in 0 05 mol/l barbitone buffer (pH 8&5) using plates 1-0 mm thick. Precipitin-inhibition studies w%Nere carried out using absorbed antisera which wNere treated with successive additions of freeze-dried tumour or normal extracts. The antisera were incubated at 37°C for 2 h and at 4°C overniight after each addition of extract and the centrifuged antiserum tested by direct double diffusion against a primary and secondary bronchial tumour extract (10 mg/ml). Interaction betwreen these extracts and the antiserum absorbed with the standard amounts of normal extracts was previously shown to give a reproducible sharp pattern of a single tumour associated precipitin band.
RESULTS
Initial studies were made with aintiserum G54. All antiserum bleeds were absorbed as described earlier and tested against various bronchial tumour and normal lung extracts. Bleeds 1 and 2 produced two precipitin arcs (Fig. 1 sorbed antisera showed multiple precipitin lines when tested against tumour and normal tissue extracts and tumour distinctive lines could not be resolved. After absorption with pooled normal lung extracts and pooled normal human plasma, a single precipitin line was obtained with tumour extracts. This line was shown to be identical to the line nearest the antiserum well given by bleeds 1 and 2 of antiserum G 54 (Fig. 1) . Antibodies to the second antigen could not be detected in this case.
Extracts of the following tissues have been studied: 4 primary bronchial adenocarcinomata, 7 liver metastases from bronchial tumour (adenocarcinoma and squamous cell carcinoma) and 9 specimens devoid of malignant disease. All the tumour extracts gave the same single reproducible precipitin line at 5 mg/ml whereas the normal extracts failed to react at 75 mg/ml and at 100 mg/ml, except in the cases where the normal and tumour were obtained from the same specimen; in these cases a very weak line of continuity with the tumour line was observed at the higher concentration of normal tissue. This result suggests possible microscopic tumour infiltration or disturbance of local cellular metabolism in the apparently normal tissue (Khoo et al., 1973) . Precipitin-inhibition reactions have been designed to determine the minimum amounts of various tissue extracts required to inhibit the formation of the tumour associated precipitin arcs. The results, summarized in the Table, have been shown to be reproducible and independent of whether the inhibiting extract was added to the antiserum in separate serially diluted solutions or as a freeze-dried solid added successively as described earlier. The latter method was used routinely to conserve antisera. Four antisera were used, MF 3 bleed 5, MF 4 bleed .5 and 2 separate pools consisting of bleeds 1 and 2 of antiserum G 54 and various bleeds of antisera MF 3 and MF 4. In all cases using extracts of tumours, inhibition was achieved with low levels of antigen (2-4 mg/ml), depending on the antiserum (Fig. 2a) . Normal extracts inhibited at concentrations greater than 100 mg/ml in excess of the standard 40 mg/ml used in the initial absorption. Figure 2b shows that absorption of the antiserum with 100 mg/ml of normal extract still fails to inhibit the reaction. These results clearly indicate a significant difference in the concentration of antigen in bronchial tumours and their metastases in liver, compared with normal lung tissue.
The tumour associated antigen was found to be soluble in 50% saturated ammonium sulphate solution and saline at neutral and acid pH. The elution pattern of an extract of primary bronchial tumour from a Sephadex G-200 column showed 3 major peaks (Fig. 3) and immunodiffusion tests showed the antigenic activity to be associated with the second peak. Using a calibrated column, this peak was eluted at approximately 300 ml, indicating a molecular size of 4 0 x 104 D. An approximately three-fold purification of the antigen was obtained, based on the weight of the active fraction after dialysis and freeze-drying. Further purification of the antigen was achieved using preparative isotachophoresis. In preliminary studies, Ampholine spacers from pH 5-10 were incorporated in the sample. The elution pattern shows 5 major peaks (Fig. 4) .
The eluate was collected in 5 ml fractions and every fifth fraction tested by double diffusion against an absorbed antiserum. Antigenic activity was associated with peak IV eluted at 300 ml, indicating the antigen to be essentially basic in character. An approximately 20-fold purification of the antigen was obtained at this stage based on the weight of active material after dialysis and freeze-drying and assuming that losses of antigen were minimal. The ultraviolet spectrum of fraction IV (A max, 278 nm, A min 252 nm) indicates that nucleic acid is probably absent from this fraction.
The antigen could not be recovered from perchloric acid extracts of both primary and secondary bronchial tumours. It was shown by double diffusion experiments to be immunologically distinct from CEA and our antisera MF 3 Yachi et al. (1968) . The latter antigen was also shown to be cross-reactive with a foetal antigen and appeared in extracts of tumours from other organs. CEA and alpha-foetoprotein are also present in normal and foetal tissues and there is evidence that such oncofoetal antigens may be associated not only with malignant disease but also with pathological conditions in which cell regeneration is prevalent.
One major difficulty when using heterologous antisera prepared by inoculating animals with semi-purified extracts of tumours is adequate absorption of the antisera with respect to anti-normal components (Witebskey, Rose and Shulman, 1956; Gold, 1971) . This has been emphasized by Yachi et al. (1968) , who examined various absorption methods. Gold and Freedman (1965) used absorbed heterologous anti-CEA antisera and compared their results with an unabsorbed antiserum raised by injecting colon tumour extract in rabbits which were made tolerant to normal colon components during neonatal life. Although true immunological tolerance is difficult to achieve, both methods produced specific anti-CEA antisera. Another method which may have wide application in the future involves the use of immunoadsorbent columns for isolating antibodies specific for human lung carcinoma antigens (Watson, Smith and Levy, 1974) . In the present preliminary study, antisera were absorbed with normal lung, liver and spleen tissue extracts at concentrations up to 200 mg/ml although in conitrast to the findings of Yachi et al. (1968) 60 mg of protein/ml of antiserum was adequate for complete absorption of antinormal antibodies. Although the antisera were coloured, we had no difficulty in observing precipitin arcs even after the antisera had been stored for several months at -20°C.
Autolysis and bacterial contamination of surgically removed tissue and autopsy specimens are difficult to avoid completely and could lead to proteolytic degradation of tissues, rendering them incapable of effective absorption of antinormal antibodies and in the case of tumour tissue to the isolation of artefacts.
Using saline extracts and antisera MF3 and MF4, we have consistently found the tumour antigen in all bronchial tumours studied by double diffusion. It can be distinguished from the antigens described by Yachi et al. (1968) and Sega et al. (1974) by its significantly smaller molecular size and its cationic mobility. It is similar, however, in its solubility in ammonium sulphate solution and its stability to acid and heat. An increase in the concentration of basic proteins in phosphate-saline extracts of bronchogenic tumours has previously been observed by Louis, Blunck and Richmond (1973) using agarose gel electrophoresis. No attempt, however, was made to isolate and further characterize these components.
The occurrence of our antigen in foetal tissue and its cross-reactivity with antigens extracted from tumours of different origin and histological types are presently being studied.
